Studies have shown that immune infiltration by CD8+ cytotoxic T cells is significantly correlated with improved clinical outcome in non-small cell lung cancer (NSCLC) (Johnson et al., 2000; Welsh et al., 2005; Al-Shibli et al., 2008; Kawai et al., 2008). Here, CD8A is linked to non-small cell lung carcinoma.